These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6171687)

  • 1. Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
    Chrysant SG; Luu TM; Danisa K; Kem DC; Manion CV
    J Cardiovasc Pharmacol; 1980; 2(2):205-14. PubMed ID: 6171687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hemodynamic and metabolic effects of trimazosin in essential hypertension.
    Chrysant SG; Miller RF; Brown JL; Danisa K
    Clin Pharmacol Ther; 1981 Nov; 30(5):600-4. PubMed ID: 7028356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of trimazosin on hemodynamics in chronic heart failure.
    Orlando JR; Danahy DT; Lurie M; Aronow WS
    Clin Pharmacol Ther; 1978 Nov; 24(5):531-6. PubMed ID: 359215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertension.
    Nelson GI; Silke B; Hussain M; Verma SP; Taylor SH
    Am Heart J; 1984 Jul; 108(1):124-31. PubMed ID: 6731261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of trimazosin in patients with left ventricular failure.
    Franciosa JA; Cohn JN
    Clin Pharmacol Ther; 1978 Jan; 23(1):11-8. PubMed ID: 618705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients.
    Chrysant SG
    Am Heart J; 1983 Nov; 106(5 Pt 2):1243-50. PubMed ID: 6356852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
    Kawashima S; Liang CS
    Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
    Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
    Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate hemodynamic effects of urapidil in patients with essential hypertension.
    Kobrin I; Amodeo C; Ventura HO; Messerli FH; Frohlich ED
    Am J Cardiol; 1985 Mar; 55(6):722-5. PubMed ID: 3976516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
    Chrysant SG; Adamopoulos P; Tsuchiya M; Frohlich ED
    Am Heart J; 1976 Sep; 92(3):335-9. PubMed ID: 782220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic and renal effects of a novel prostaglandin analogue (L644,122(+isomer)) in sheep.
    Tresham JJ; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1987 Oct; 14(10):779-84. PubMed ID: 3327638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.